Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.21.2
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jan. 01, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]            
Total revenues $ 442,408 $ 301,207 $ 987,573 $ 512,674    
Operating income (loss) 5,571 27,179 44,008 (13,581)    
Depreciation and amortization 20,573 22,266 40,561 44,318    
Loss from investment in investees (67) (189) (110) (323)    
Assets 2,421,650   2,421,650     $ 2,473,063
Goodwill 677,360   677,360   $ 718,625 680,602
United States            
Segment Reporting Information [Line Items]            
Total revenues 402,291 265,890 915,163 446,761    
Ireland            
Segment Reporting Information [Line Items]            
Total revenues 12,088 16,847 19,218 28,749    
Chile            
Segment Reporting Information [Line Items]            
Total revenues 18,657 11,152 32,809 22,002    
Spain            
Segment Reporting Information [Line Items]            
Total revenues 5,437 4,136 11,356 8,292    
Israel            
Segment Reporting Information [Line Items]            
Total revenues 724 1,183 3,235 2,890    
Mexico            
Segment Reporting Information [Line Items]            
Total revenues 3,039 1,866 5,457 3,708    
Other            
Segment Reporting Information [Line Items]            
Total revenues 172 133 335 272    
Corporate            
Segment Reporting Information [Line Items]            
Operating income (loss) (10,719) (7,760) (20,138) (16,263)    
Depreciation and amortization 0 0 0 59    
Loss from investment in investees 0 0 0 0    
Assets 36,181   36,181     28,080
Goodwill 0   0     0
Pharmaceutical | Operating Segments            
Segment Reporting Information [Line Items]            
Operating income (loss) (13,710) (5,996) (32,868) (20,121)    
Depreciation and amortization 7,007 7,119 14,420 14,240    
Loss from investment in investees (67) (189) (110) (323)    
Assets 1,158,213   1,158,213     1,176,245
Goodwill 242,551   242,551     245,793
Diagnostics | Operating Segments            
Segment Reporting Information [Line Items]            
Operating income (loss) 30,000 40,935 97,014 22,803    
Depreciation and amortization 13,566 15,147 26,141 30,019    
Loss from investment in investees 0 0 0 0    
Assets 1,227,256   1,227,256     1,268,738
Goodwill 434,809   434,809     $ 434,809
Services            
Segment Reporting Information [Line Items]            
Total revenues 397,197 250,971 904,149 421,811    
Services | Corporate            
Segment Reporting Information [Line Items]            
Total revenues 0 0 0 0    
Services | Pharmaceutical | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues 0 0 0 0    
Services | Diagnostics | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues 397,197 250,971 904,149 421,811    
Products            
Segment Reporting Information [Line Items]            
Total revenues 35,663 29,356 69,608 60,430    
Products | Corporate            
Segment Reporting Information [Line Items]            
Total revenues 0 0 0 0    
Products | Pharmaceutical | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues 35,663 29,356 69,608 60,430    
Products | Diagnostics | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues 0 0 0 0    
Transfer of intellectual property and other            
Segment Reporting Information [Line Items]            
Total revenues 9,548 20,880 13,816 30,433    
Transfer of intellectual property and other | Corporate            
Segment Reporting Information [Line Items]            
Total revenues 0 0 0 0    
Transfer of intellectual property and other | Pharmaceutical | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues 9,548 14,686 13,816 24,239    
Transfer of intellectual property and other | Diagnostics | Operating Segments            
Segment Reporting Information [Line Items]            
Total revenues $ 0 $ 6,194 $ 0 $ 6,194